Sign Up to like & get
recommendations!
1
Published in 2022 at "Expert Review of Clinical Immunology"
DOI: 10.1080/1744666x.2022.2060204
Abstract: ABSTRACT Background Tocilizumab is a recombinant humanized monoclonal immunoglobulin G1 antibody against the interleukin-6 receptor (IL-6 R). MSB11456 is a proposed tocilizumab biosimilar. Objectives To assess the pharmacokinetic and pharmacodynamic similarity of MSB11456 to both…
read more here.
Keywords:
approved tocilizumab;
proposed tocilizumab;
msb11456 licensed;
licensed approved ... See more keywords